AC Immune Holds Annual General Meeting of Shareholders
- Shareholders approved all resolutions as proposed by the Board of Directors
AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the Company held its Annual General Meeting per Swiss law. Shareholders cast their votes in person at the Annual General Meeting or through the Independent Proxy appointed by the shareholders.
Shareholders re-elected Douglas Williams, Monika Bütler, Carl June, Werner Lanthaler, Andrea Pfeifer, Monica Shaw and Roy Twyman to their positions on the Board of Directors. Alan Colowick and Tom Graney did not stand for re-election and we thank them for their contributions. Douglas Williams will continue to serve as Chair of the Board.